ANTHEM-HFrEF Pivotal Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 533 participants.

Also called NCT03425422

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 533 participants (enrolled count) (from the registry)
Sponsor
  • LivaNova Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03425422
Other papers using this trial's data
  • Vagal Nerve Stimulation in Patients With Heart Failure and Reduced Ejection Fraction: The ANTHEM-HFrEF Trial Journal of the American College of Cardiology, 2026-06-30 DOI, PubMed 42159539

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT03425422. Randomized; no masking; primary purpose treatment. Start 2018-05-01 (actual); primary completion 2023-05-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ANTHEM-HFrEF Pivotal Study
Condition
Heart Failure
Condition
Heart Failure, Congestive
Condition
Heart Failure, Systolic
Intervention (Device)
VITARIA System
Lead sponsor
LivaNova (class: industry)

Record details

Record id
cardio:ct-nct03425422
Content hash
084619340b34d4eb271ff47a1cc11fd9e5bc614a42cd06a89c101fbf8f4a8c72